Hammerhead ribozyme against γ-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (10) , 803-814
- https://doi.org/10.1038/sj.cgt.7700371
Abstract
Multidrug resistance in cancer cells is often associated with an elevation in the concentration of glutathione (GSH) and the expression of γ-glutamylcysteine synthetase (γ-GCS), a rate-limiting enzyme for GSH. We constructed a hammerhead ribozyme against a γ-GCS heavy subunit (γ-GCSh) mRNA transcript and transfected it to human colonic cancer cells (HCT8DDP) resistant to cisplatin (CDDP). The effect of the ribozyme transfection on the drug resistance of cancer cells was studied. (a) Transfection of the ribozyme decreased the GSH level and the efflux of CDDP–GSH adduct, resulting in higher sensitivity of the cells to CDDP. (b) The transfection suppressed the expression of ATP-binding cassette (ABC) family of transporters such as MRP1, MRP2, and MDR1, and stimulated the expression of mutant p53. (c) An electrophoretic mobility shift assay showed that mutant p53 suppresses the SP1–DNA binding activity, suggesting that this mutant p53 is functional and it, in turn, suppresses the expression of ABC transporters. Collectively, transfection of anti–γ-GCSh ribozyme reduced the synthesis of GSH and the expression of ABC transporters, which causes an increase in the sensitivity of cancer cells to anticancer drugs. Suppression of the SP1–DNA binding activity by p53 may be a factor of down-regulation of ABC transporters. Cancer Gene Therapy (2001) 8, 803–814Keywords
This publication has 44 references indexed in Scilit:
- Down-regulation of Intrinsic P-glycoprotein Expression in Multicellular Prostate Tumor Spheroids by Reactive Oxygen SpeciesJournal of Biological Chemistry, 2001
- Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cellsJournal of Clinical Investigation, 2000
- Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1Oncogene, 1999
- Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1998
- Expression of Multidrug Resistance Protein/GS-X Pump and γ-Glutamylcysteine Synthetase Genes Is Regulated by Oxidative StressJournal of Biological Chemistry, 1998
- Hammerhead Ribozymes against γ-Glutamylcysteine Synthetase mRNA Down-Regulate Intracellular Glutathione Concentration of Mouse Islet CellsBiochemical and Biophysical Research Communications, 1998
- Human Canalicular Multispecific Organic Anion Transporter (cMOAT) Is Expressed in Human Lung, Gastric, and Colorectal Cancer CellsBiochemical and Biophysical Research Communications, 1997
- Long Exposure to High Glucose Concentration Impairs the Responsive Expression of γ-Glutamylcysteine Synthetase by Interleukin-1β and Tumor Necrosis Factor-α in Mouse Endothelial CellsPublished by Elsevier ,1996
- Coordinated Induction of / Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia CellsPublished by Elsevier ,1996
- Evidence that SP1 Modulates Transcriptional Activity of the Multidrug Resistance-Associated Protein GeneDNA and Cell Biology, 1996